(Q38045704)

27 August 2017

0 references

HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis (English)

1 reference

27 August 2017

1 reference

1 reference

1 reference

M E Scheurer

1

1 reference

27 August 2017

J C Pritchett

2

1 reference

27 August 2017

E S Amirian

3

1 reference

27 August 2017

N R Zemke

4

1 reference

27 August 2017

P Lusso

5

1 reference

27 August 2017

P Ljungman

6

1 reference

27 August 2017

language of work or name

English

0 references

publication date

24 September 2012

1 reference

Bone Marrow Transplantation

27 August 2017

published in

1 reference

27 August 2017

volume

48

1 reference

27 August 2017

issue

4

1 reference

27 August 2017

page(s)

574-580

1 reference

Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

High incidence of human herpes virus 6-associated encephalitis/myelitis following a second unrelated cord blood transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Differentiation between two distinct classes of viruses now classified as human herpesvirus 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

A population-based study of primary human herpesvirus 6 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Three new human herpesviruses (HHV6, 7, and 8).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Human herpesvirus-6: clinical implications of a recently discovered, ubiquitous agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Deciphering the clinical impact of acute human herpesvirus 6 (HHV-6) infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Human herpesvirus 6 limbic encephalitis after stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Long-term outcome of human herpesvirus-6 encephalitis after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Symptomatic generalized epilepsy after HHV6 posttransplant acute limbic encephalitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

High intrahepatic HHV-6 virus loads but neither CMV nor EBV are associated with decreased graft survival after diagnosis of graft hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Human herpesvirus type 6 reactivation after haematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Human herpesvirus-6 infections in kidney, liver, lung, and heart transplantation: review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Confirmation of the low clinical effect of human herpesvirus-6 and -7 infections after renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Relationship among human herpesvirus 6 reactivation, serum interleukin 10 levels, and rash/graft-versus-host disease after allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Lymphoproliferative response to herpes simplex virus type 1, cytomegalovirus, Epstein-Barr virus, varicella zoster virus, human herpes virus 6, 7, and 8 antigen stimulation in pediatric allogeneic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Human herpesvirus 6 (HHV-6).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

CD46 is a cellular receptor for human herpesvirus 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Human Herpesvirus 6 and Measles Virus Employ Distinct CD46 Domains for Receptor Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Intracellular processing of human herpesvirus 6 glycoproteins Q1 and Q2 into tetrameric complexes expressed on the viral envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Quantitative expression analysis of HHV-6 cell receptor CD46 on cells of human cord blood, peripheral blood and G-CSF mobilised leukapheresis cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Assessment of human herpesvirus-6 infection in mesenchymal stromal cells ex vivo expanded for clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

High Concentrations of Intrathecal Interleukin-6 in Human Bacterial and Nonbacterial Meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Multicenter comparison of PCR assays for detection of human herpesvirus 6 DNA in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Detection of human herpesvirus-6 in cerebrospinal fluid of patients with encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Chromosomally integrated human herpesvirus 6: questions and answers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Quantitation of human herpesvirus-6A, -6B and -7 DNAs in whole blood, mononuclear and polymorphonuclear cell fractions from healthy blood donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Detection of human herpesvirus-6 DNA by polymerase chain reaction in serum or plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Multicenter external quality assessment of molecular methods for detection of human herpesvirus 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

HHV-6 encephalitis in pediatric unrelated umbilical cord transplantation: a role for ganciclovir prophylaxis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Safety of pre-engraftment prophylactic foscarnet administration after allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Prevalence of human herpesvirus 6 antibodies and DNA in allogeneic stem cell transplant patients: two-year single centre experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Human herpesvirus 6 variant B infection in adult patients after unrelated cord blood transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

The Complex Relationship between Human Herpesvirus 6 and Acute Graft-versus-Host Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Characteristics and Acquisition of Human Herpesvirus (HHV)–7 Infections in Relation to Infection with HHV‐6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Human herpesvirus 6-associated limbic encephalitis in adult recipients of unrelated umbilical cord blood transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Umbilical cord blood transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Severe Infections after Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation in Adults: Comparison of Cord Blood Transplantation with Peripheral Blood and Bone Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

7 January 2021

Infectious complications after unrelated umbilical cord blood transplantation in adult patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

7 January 2021

Human herpes virus 6 infection is a hallmark of cord blood transplant in adults and may participate to delayed engraftment: a comparison with matched unrelated donors as stem cell source

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

7 January 2021

HLA-mismatched CD34-selected stem cell transplant complicated by HHV-6 reactivation in the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

7 January 2021

Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

7 January 2021

HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

7 January 2021

Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

7 January 2021

Growth properties of human herpesvirus-6 strain Z29

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

7 January 2021

Changes of cytokines during the course of graft-versus-host disease following bone marrow transplantation: a case report

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

7 January 2021

Apoptosis under hypercytokinemia is a possible pathogenesis in influenza-associated encephalopathy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

7 January 2021

Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

7 January 2021

Reactivation of human herpesvirus 6 (HHV-6) infection in patients with connective tissue diseases

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

7 January 2021

IgG subclasses and DNA detection of HHV-6 and HHV-7 in healthy individuals

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

7 January 2021

Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Preface

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.180

7 January 2021

Identifiers

DOI

10.1038/BMT.2012.180

1 reference

Dimensions Publication ID

27 August 2017

1053094923

0 references

1 reference